{"lang": "en", "author_id": "3310124155", "possibly_sensitive": false, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10040666972", "name": "The New York Times"}}], "created_at": "2020-05-25T22:48:06.000Z", "referenced_tweets": [{"type": "replied_to", "id": "1264988849085779969"}], "entities": {"annotations": [{"start": 134, "end": 136, "probability": 0.7454, "type": "Organization", "normalized_text": "FDA"}], "mentions": [{"start": 0, "end": 8, "username": "nytimes", "id": "807095"}], "urls": [{"start": 139, "end": 162, "url": "https://t.co/meOFm8hGNK", "expanded_url": "https://www.benzinga.com/node/15717785", "display_url": "benzinga.com/node/15717785", "status": 200, "unwound_url": "https://www.benzinga.com/general/biotech/20/04/15717785/diffusion-pharma-to-evaluate-drug-in-covid-19-related-respiratory-distress-sending-stock-higher"}]}, "conversation_id": "1264988849085779969", "in_reply_to_user_id": "807095", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter Web App", "text": "@nytimes Diffusion Pharmaceutical (DFFN) is developing a drug treatment for Covid-19 patients!!! They are currently in talks with the FDA!\nhttps://t.co/meOFm8hGNK", "id": "1265052049248567298", "reply_settings": "everyone"}